Page breadcrumb nav

VAERS Report 2156736

Case Report Section

Détails du rapport Vaer

Âge: 54 ans

Genre: Female

Région : Outside US

Patient décédé?
Non
Renseignements sur les vaccins

Nom: COVID19 (COVID19 (PFIZER-BIONTECH))

Type : Coronavirus 2019 vaccine

Fabricant: PFIZER

Lot: ff8288


Date de réception du rapport
2022-03-04
Date à laquelle le formulaire est complèté
Date de vaccination
2021-10-15
Date d’apparition
0
Nombre de jours (date d’apparition – date de vaccination)
0
Description de l’événement indésirable

itching; skin rash; malaise; joint pain; air hunger; poor concentration; painful arm; feverish; cheek swelling; swollen lymph nodes; exercise induced palpitation; painful arm refers to arm of the injection site; taste chemical; fatigue; rashes and itching that were a symptom of long covid/significant worsening of long covid symptoms; swollen lips; swollen tongue; abdominal pain; nausea; headache; this is a spontaneous report received from a contactable reporter (consumer or other non hcp) from the regulatory agency. regulatory number: gb-mhra-webcovid-202202151512547850-hchca. other case identifier(s): gb-mhra-adr 26607814. a 54-year-old female patient (not pregnant) received bnt162b2 (comirnaty), administered in arm, administration date 15oct2021 (lot number: ff8288) at the age of 54 years as dose 1, single for covid-19 immunisation. relevant medical history included: "myalgic encephalomyelitis" (not ongoing), notes: thought to have a moderate impact on immunity.; "coeliac disease" (ongoing); "miscarriage" (unspecified if ongoing), notes: she had previously been treated by a reproductive immunologist for recurrent miscarriage.; "allergy to chemicals" (ongoing), notes: to some medical adhesives; "covid-19", start date: 26mar2020 (ongoing), notes: and again on 29mar2020 assumed to be alpha variant; "immunodeficiency" (unspecified if ongoing), notes: has an illness or condition, not listed above, which reduces the immune response; "long covid" (ongoing); "itching" (unspecified if ongoing); "allergy" (unspecified if ongoing); "rashes" (unspecified if ongoing). concomitant medication included: cetrizine taken for allergy, pruritus, rash, start date: jun2020. the following information was reported: pruritus (medically significant), outcome "not recovered", described as "itching"; rash (medically significant) with onset 18oct2021, outcome "recovered" (16dec2021), described as "skin rash"; condition aggravated (medically significant) with onset 15oct2021, outcome "unknown", described as "rashes and itching that were a symptom of long covid/significant worsening of long covid symptoms"; lip swelling (medically significant) with onset 15oct2021, outcome "recovered" (29oct2021), described as "swollen lips"; swollen tongue (medically significant) with onset 15oct2021, outcome "recovered" (15oct2021), described as "swollen tongue"; abdominal pain (medically significant) with onset 15oct2021, outcome "recovered" (18oct2021), described as "abdominal pain"; nausea (medically significant) with onset 15oct2021, outcome "recovered" (18oct2021), described as "nausea"; headache (medically significant) with onset 15oct2021, outcome "recovered" (28oct2021), described as "headache"; pain in extremity (medically significant) with onset 16oct2021, outcome "recovered" (18oct2021), described as "painful arm"; dysgeusia (medically significant) with onset 15oct2021, outcome "recovered" (17oct2021), described as "taste chemical"; pyrexia (medically significant) with onset 16oct2021, outcome "recovering", described as "feverish"; swelling face (medically significant) with onset 16oct2021, outcome "recovered" (06nov2021), described as "cheek swelling"; lymphadenopathy (medically significant) with onset 16oct2021, outcome "not recovered", described as "swollen lymph nodes"; malaise (medically significant) with onset 17oct2021, outcome "not recovered", described as "malaise"; arthralgia (medically significant) with onset 17oct2021, outcome "recovering", described as "joint pain"; dyspnoea (medically significant) with onset 17oct2021, outcome "unknown", described as "air hunger"; disturbance in attention (medically significant) with onset 16oct2021, outcome "unknown", described as "poor concentration"; fatigue (medically significant) with onset 15oct2021, outcome "unknown", described as "fatigue"; palpitations (medically significant) with onset 16oct2021, outcome "recovering", described as "exercise induced palpitation"; vaccination site pain (medically significant) with onset 16oct2021, outcome "unknown", described as "painful arm refers to arm of the injection site". the patient underwent the following laboratory tests and procedures: covid-19 virus test: inconclusive test. clinical course details: patient had myalgic encephalomyelitis, thought to have a moderate impact on immunity. she was diagnosed with covid 19 in mar2020 specifically on 26mar2020 (also reported on 24feb2020) and again on 29mar2020 (assumed to be alpha variant) and has since had long covid. she had previously been treated by a reproductive immunologist for recurrent miscarriage. she also has coeliac disease and an allergy to some medical adhesives. the swelling of the tongue and lips were first noticed 25 minutes after the injection, they worsened slowly over the next half hour and then were stable for a few days before slowly receding. throat was not dangerously restricted. she was taking cetirizine for rashes and itching that were a symptom of long covid. vaccination was followed by a significant worsening of long covid symptoms, which over months have reduced to the extent its not possible to ascertain whether they continue to be worse than they would have been without the vaccination. the painful arm refers to arm of the injection site. patient has not tested positive for covid-19 since having the vaccine. patient is not enrolled in clinical trial. no follow-up attempts are possible. no further information is expected

Données de laboratoire
test name: covid-19 virus test; result unstructured data: test result:inconclusive test
Liste des symptômes
pruritus malaise fatigue rash nausea headache arthralgia pain in extremity abdominal pain lymphadenopathy condition aggravated dysgeusia dyspnoea palpitations pyrexia swollen tongue swelling face disturbance in attention lip swelling sars-cov-2 test vaccination site pain
Patient décédé?
Non
Date de décès
N/A
Anomalie congénitale
false
Vaccin administré par :
Other
Vaccin acheté par :
Inconnu
Visite d’un patient à l’urgence?
Non
Patient hospitalisé?
Non
Séjour à l’hôpital
Non
Nombre de jours à l’hôpital
Non spécifié
Invalidité permanente?
Non
Allergies:
na
Maladie actuelle
allergy to chemicals (to some medical adhesives); coeliac disease; covid-19 (and again on 29mar2020 assumed to be alpha variant); long covid